Biogen Idec And Neurimmune Announce Agreement On Three Neurodegenerative Disease Programs
Links shared publicly online about this topic.
- 636total visits
Biogen Idec And Neurimmune Announce Agreement On Three Neurodegenerative Disease Programs
Biogen Idec (NASDAQ: BIIB) and Neurimmune Holding AG have announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunother
View full resource at medicalnewstoday.com
Tags: Disease and Condition, Pharma, Biogen Idec, disease
Most Recently Shared on December 22, 2010 at 2:05 pm By:
Biogen Idec And Neurimmune Announce Agreement On Three Neurodegenerative Disease Programs http://mnt.to/3Pp8 #pharma #pharmaceutical
Advertisement
